Company profile
Sequential Skin Ltd
Sequential Skin - Skin Microbiome Test Kit - Skin Health Check
Sequential Skin has developed the Skin Microbiome Test Kit to discover the state of skin microbiomes. You can do Skin Health Check to find what your skin needs.
Company events
Reference milestones and recent Companies House filing stream events.
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts due
Accounts DueNext accounts due date
Change Person Director Company With Change Date
OfficersCH01 | Transaction MzUyOTg3MDczOWFkaXF6a2N4
Published 01 Jul 2026 14:54
Change Person Director Company With Change Date
OfficersCH01 | Transaction MzUyOTg3MDUxMWFkaXF6a2N4
Published 01 Jul 2026 14:53
Change To A Person With Significant Control
Persons-with-significant-controlPSC04 | Transaction MzUyOTg3MDQ5OGFkaXF6a2N4
Published 01 Jul 2026 14:52
Change To A Person With Significant Control
Persons-with-significant-controlPSC04 | Transaction MzUyOTg3MDM1MWFkaXF6a2N4
Published 01 Jul 2026 14:51
Change Person Director Company With Change Date
OfficersCH01 | Transaction MzUyOTg3MDIzMWFkaXF6a2N4
Published 01 Jul 2026 14:50
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Resolution
ResolutionRESOLUTIONS | Transaction WUVZSUVTQVphZGlxemtjeA | Paper/PDF filed
Published 04 Apr 2026 05:29
Memorandum Articles
IncorporationMA | Transaction MzUxMjI2MDk3M2FkaXF6a2N4 | Paper/PDF filed
Published 03 Apr 2026 16:19
Accounts filed
AccountsLast accounts made up date
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Rapid Identification of Inflammatory Skin Diseases Using Advanced Skin and Saliva Microbiome Panel
1 Apr 2025 to 31 Mar 2028
Chronic and recurrent inflammatory skin disorders (ISDs), such as atopic dermatitis and psoriasis, affect 20-25% population and can significantly impact physical and mental-wellbeing. ISDs are commonly diagnosed and managed in primary care, but long waits for definitive diagnoses and presentation/pathogenesis-related complexities across disparate populati...
Sequential Skin: Revolutionising atopic dermatitis diagnosis through a novel skin microbiome test.
1 Oct 2022 to 31 Mar 2024
Atopic dermatitis (AD) is a multifactorial chronic and recurrent inflammatory skin disease, affecting 1-in-5 UK children and 1-in-10 adults. Circa.29% are moderate/severe cases -- affecting over 1.97million patients in the UK alone -- with healthcare and socio-economic costs exceeding £723million annually. With no definitive cure, a significant therapeuti...